First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake-Reference-Cited by-同舟云学术

First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake

Published:2016-08-11 Issue:12 Volume:57 Page:1858-1864
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Pandit-Taskar Neeta,O’Donoghue Joseph A.,Ruan Shutian,Lyashchenko Serge K.,Carrasquillo Jorge A.,Heller Glenn,Martinez Danny F.,Cheal Sarah M.,Lewis Jason S.,Fleisher Martin,Keppler Jennifer S.,Reiter Robert E.,Wu Anna M.,Weber Wolfgang A.,Scher Howard I.,Larson Steven M.,Morris Michael J.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using 111In-J591: Lesion Detectability and Dosimetric Projections for 90Y Radioimmunotherapy

2. Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer

3. 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

4. Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology

5. ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Chelator–Minibody Theranostic Agents for⁸⁹Zr PET Imaging and¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer;Journal of Nuclear Medicine;2024-08-14

2. First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-10

3. Combining Desferriferrioxamine B and 1‐Hydroxy‐2‐Piperidone ((PIPO)H) to Chelate Zirconium. Solution Structure of a Model Complex of the [⁸⁹Zr]Zr−DFOcyclo*−mAb Radioimmunoconjugate;ChemPlusChem;2024-04-13

4. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19

5. Synthesis and evaluation of bifunctional DFO2K: a modular chelator with ideal properties for zirconium-89 chelation;Dalton Transactions;2024